Concepedia

Andrew J. Li

AJ

Statistics

Publications

4

Citations

105

H-Index

4

Active since

2020

Affiliations

National Center for Advancing Translational Sciences(Current)

National Institutes of Health

Andrew J. Li is an author at National Center for Advancing Translational Sciences specializing in medicine, drug discovery, and drug analysis.

ORCID

Top concepts

Publications per year

2020–2023

4

Publications

4

Identification of Compounds for Butyrylcholinesterase Inhibition

Shuaizhang Li, Andrew J. Li, Jameson Travers et al. · SLAS DISCOVERY · 2021 · 53 citations · Full text

Acetylcholinesterase Inhibition Assays for High-Throughput Screening

Shuaizhang Li, Andrew J. Li, Jinghua Zhao et al. · Methods in molecular biology · 2022 · 22 citations · Full text

, , +7

A direct peptide reactivity assay using a high-throughput mass spectrometry screening platform for detection of skin sensitizers

Zhengxi Wei, Yuhong Fang, Maya L. Gosztyla et al. · Toxicology Letters · 2020 · 15 citations · Full text

Identification of Potent and Selective Acetylcholinesterase/Butyrylcholinesterase Inhibitors by Virtual Screening

Tuan Xu, Shuaizhang Li, Andrew J. Li et al. · Journal of Chemical Information and Modeling · 2023 · 15 citations · Full text

1–4 of 4